Volume 33, Issue 10 , Pages 1721-1726, October 2007
Use of adaptive optics to determine the optimal ocular spherical aberration
Purpose
To explore the impact of spherical aberration (SA) on contrast sensitivity using an adaptive optics vision simulator to determine the optimal amount of SA to include in customized corrections of wavefront aberrations.
Setting
Laboratorio de Optica, Universidad de Murcia, Murcia, Spain, and AMO Groningen BV, Groningen, The Netherlands.
Methods
An adaptive optics vision simulator consisting of a wavefront sensor, a 97-segmented deformable mirror to induce and correct aberrations of the eye, and a visual testing path was constructed for this study. The deformable mirror allows the effective ocular wavefront aberration to be manipulated and the resulting visual performance to be measured simultaneously. Subjective measurements of contrast sensitivity at 15 cycles per degree were performed with a 4.8 mm pupil in 5 subjects with different levels of naturally occurring SA. Contrast sensitivity was measured when SA values of −0.09 μm, 0.0 μm, 0.09 μm, and 0.182 μm were induced when the other natural aberrations of the eye were present, when the aberrations were corrected, and at defocus values of ±0.25 diopter (D) and ±0.50 D.
Results
Subjects experienced peak contrast sensitivity performance with varying levels of SA when their natural aberrations were present; however, average contrast performance peaked at 0 μm of SA. When all higher-order aberrations were corrected, all 5 subjects' peak performance occurred at 0 μm of SA.
Conclusions
The adaptive optics vision simulator reduced the root-mean-square wavefront aberration of the eye by up to a factor of 4 and allowed noninvasive testing of the visual performance resulting from any ocular wavefront aberration introduced by customized correction procedures. This study showed that, on average, contrast performance peaked when SA was completely corrected.
To access this article, please choose from the options below
Dr. Piers is an employee of AMO Gronigen BV. None of the other authors has a financial or proprietary interest in any material or method mentioned.
Supported by AMO, Ministerio de Educacion y Ciencia, Spain, grant FIS2004-02153, and Sharp-eye EU-RTN.
PII: S0886-3350(07)01233-3
doi:10.1016/j.jcrs.2007.08.001
© 2007 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.
Volume 33, Issue 10 , Pages 1721-1726, October 2007
